InceptionR’s Gilead Sciences GILD Stock Holding History

InceptionR’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$598K	Buy	+4,291	New	+$601K	0.14%	252
2025 Q4	–	Sell	-3,622	Closed	-$402K	–	700
2025 Q3	$402K	Buy	+3,622	New	+$412K	0.1%	380
2025 Q1	–	Sell	-17,143	Closed	-$1.58M	–	665
2024 Q4	$1.58M	Buy	17,143 +4,192	+32%	+$377K	0.35%	66
2024 Q3	$1.09M	Buy	12,951 +7,347	+131%	+$561K	0.27%	109
2024 Q2	$384K	Sell	5,604 -9,027	-62%	-$602K	0.11%	355
2024 Q1	$1.07M	Buy	14,631 +7,903	+117%	+$608K	0.28%	131
2023 Q4	$545K	Sell	6,728 -1,633	-20%	-$127K	0.39%	88
2023 Q3	$627K	Buy	+8,361	New	+$643K	0.36%	96
2023 Q1	–	Sell	-10,379	Closed	-$891K	–	488
2022 Q4	$891K	Buy	+10,379	New	+$822K	0.47%	45

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

InceptionR's GILD Position: Q1 2026 in Review

InceptionR opened a new position in Gilead Sciences (GILD) in Q1 2026: 4,291 shares worth $598K. The stake represents 0.14% of the portfolio and ranks #252 among its holdings. This is a return to the name: InceptionR previously reported a position in GILD as recently as Q3 2025.

InceptionR first reported a position in GILD in Q4 2022 and has held it in 9 quarters since. The position peaked at $1.58M in Q4 2024. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

InceptionR held 4,291 shares of Gilead Sciences worth $598K as of Q1 2026.
Gilead Sciences was a new InceptionR position in Q1 2026.
Gilead Sciences made up 0.14% of InceptionR's portfolio in Q1 2026, its #252 holding.
InceptionR first reported a position in Gilead Sciences in Q4 2022 and has held it in 9 quarters since.
InceptionR's Gilead Sciences position peaked at $1.58M in Q4 2024.
2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on InceptionR's 13F filing for Q1 2026, filed 14 May 2026.